Ki | - |
EC50 | - |
IC50 | - |
Inhibition | - |
Toxicity | - |
ROS(reactive oxygen species) | - |
Metal Chelating | - |
BBB(blood-brain barrier) | - |
Target Protein | Aβ |
Effects | - |
Research Models | - |
Ref. Link |
Molecular Weight(Computed by SwissADME) | |
Hac(Computed by SwissADME) | |
Volume(Computed by ADMETlab 2.0) | |
Density(Computed by ADMETlab 2.0) | |
nRing(Computed by ADMETlab 2.0) | |
MaxRing(Computed by ADMETlab 2.0) | |
nHet(Computed by ADMETlab 2.0) | |
fChar(Computed by ADMETlab 2.0) | |
nRig(Computed by ADMETlab 2.0) | |
Flexibility(Computed by ADMETlab 2.0) | |
Stero Centers(Computed by ADMETlab 2.0) | |
LogS(Computed by ADMETlab 2.0) | |
LogD(Computed by ADMETlab 2.0) |
logP(Computed by ADMETlab 2.0) | |
TPSA(Computed by SwissADME) | |
Hbond Acceptor(Computed by SwissADME) | |
Hbond Donor(Computed by SwissADME) | |
Rotatable Bonds(Computed by SwissADME) |
GI Absorption(Computed by SwissADME) | |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | |
P-gp Substrate(Computed by SwissADME) | |
CYP1A2 Inhibitor(Computed by SwissADME) | |
CYP2C19 Inhibitor(Computed by SwissADME) | |
CYP2C9 Inhibitor(Computed by SwissADME) | |
CYP2D6 Inhibitor(Computed by SwissADME) | |
CYP3A4 Inhibitor(Computed by SwissADME) | |
log Kp(Skin Permeation)(Computed by SwissADME) |
Lipinski(Computed by SwissADME) | |
Ghose(Computed by SwissADME) | |
Veber(Computed by SwissADME) | |
Egan(Computed by SwissADME) | |
Muegge(Computed by SwissADME) | |
Bioavailability Score(Computed by SwissADME) |